Medicare Enrolled

Dr. Okan Elidemir, MD

Pediatric Hematology-Oncology · Pensacola, FL
5153 NORTH 9TH AVE., Pensacola, FL 32504
8504734516
Registered in NPPES since 2006
NPI: 1073693313 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Elidemir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Elidemir? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Elidemir

Dr. Okan Elidemir is a pediatric hematology-oncology specialist in Pensacola, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Elidemir received a total of $2,980 from 27 pharmaceutical and/or device companies across 174 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Elidemir is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $2,980 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 113896 Clear January 31, 2027 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$2,980
Total received (2018-2024)
Avg $426/year across 7 years
Top 29% in FL for pediatric hematology-oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
174
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$422
2023
$388
2022
$365
2021
$675
2020
$362
2019
$398
2018
$371

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$97
Electromed, Inc.
$72
Baxter Healthcare
$59
Philips North America LLC
$46
GlaxoSmithKline, LLC.
$39
Genentech USA, Inc.
$37
ABBVIE INC.
$26
Alcresta Therapeutics, Inc.
$24
Regeneron Healthcare Solutions, Inc.
$21
Top 3 companies account for 54.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$438
Electromed, Inc.
$383
GlaxoSmithKline, LLC.
$318
Genentech USA, Inc.
$196
Regeneron Healthcare Solutions, Inc.
$187
ABBVIE INC.
$119
Advanced Respiratory, Inc
$119
Chiesi USA, Inc.
$118
AbbVie, Inc.
$113
CHIESI USA, INC.
$109
AbbVie Inc.
$104
Nestle HealthCare Nutrition Inc.
$95
GENZYME CORPORATION
$76
Mylan Specialty L.P.
$64
Allergan Inc.
$64
Alcresta Therapeutics, Inc.
$61
Baxter Healthcare
$59
VERTEX PHARMACEUTICALS INCORPORATED
$56
Philips Electronics North America Corporation
$55
NESTLE HEALTHCARE NUTRITION INC.
$52
Philips North America LLC
$46
VIVUS LLC
$39
Vertex Pharmaceuticals Incorporated
$32
Gilead Sciences, Inc.
$29
Insmed, Inc.
$22
PARI Respiratory Equipment, Inc.
$12
Novartis Pharmaceuticals Corporation
$12
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · Arikayce · BETHKIS · BRONCHITOL · CREON · Creon · DUPIXENT · FASENRA · Hillrom - Vest System Model 105 Home Care · Kitabis Pak · Life 2000 Ventilation System · NUCALA · PANCREAZE · PERTZYE · Pulmozyme · Qsymia · RELIZORB · SMARTVEST · SYMDEKO · TEFLARO · TEZSPIRE · TOBI PODHALER · TOBI Podhaler · The Vest System Model 105 Home Care · Tobi Podhaler · Xolair · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric hematology-oncology specialist in Pensacola?
Compare pediatric hematology-oncologists in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse pediatric hematology-oncologists nearby

Geographic Context

Pediatric hematology-oncologists in nearby ZIP areas
4
County median income
$65,715
Nearest hospital to ZIP centroid (approximate)
SACRED HEART HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Elidemir is a pediatric hematology-oncology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Elidemir receive payments from pharmaceutical companies?
Yes. Dr. Elidemir received a total of $2,980 from 27 companies across 174 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Elidemir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Hematology-Oncologists in Pensacola
Browse pediatric hematology-oncologists in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Hematology-Oncologists in FL
Pediatric hematology-oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Hematology-Oncologists in FL
Which FL pediatric hematology-oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Electromed, Inc. Payments to Doctors
See all physicians who received payments from Electromed, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →